|
MechanismTubulin inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Canada |
First Approval Date31 Dec 1962 |
100 Clinical Results associated with Transdermal Corp.
0 Patents (Medical) associated with Transdermal Corp.
100 Deals associated with Transdermal Corp.
100 Translational Medicine associated with Transdermal Corp.